Showing results (1-10 of 624) with videos related to
Sort By:
Pageof 63
Clinical Advances in Hematology & Oncology : H&O|June 13, 2019
The evolving understanding of prognosis in post-essential thrombocythemia myelofibrosis and post-polycythemia vera myelofibrosis vs primary myelofibrosisLucia Masarova, Srdan VerstovsekExpert Opinion on Emerging Drugs|May 4, 2019
Emerging drugs for essential thrombocythemiaLucia Masarova, Srdan VerstovsekJournal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 23, 2018
Therapeutic Approach to Young Patients With Low-Risk Essential Thrombocythemia: Primum Non NocereLucia Masarova, Srdan VerstovsekCancers|October 14, 2020
Novel Concepts of Treatment for Patients with Myelofibrosis and Related NeoplasmsPrithviraj Bose, Lucia Masarova, Srdan Verstovsek[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|October 11, 2019
Novel treatment strategies for myeloproliferative neoplasmsPrithviraj Bose, Lucia Masarova, Srdan VerstovsekClinical Advances in Hematology & Oncology : H&O|February 13, 2023
A review of essential thrombocythemia and its complicationsRodrick Babakhanlou, Lucia Masarova, Srdan VerstovsekCurrent Hematologic Malignancy Reports|June 23, 2019
The Rationale for Immunotherapy in Myeloproliferative NeoplasmsLucia Masarova, Prithviraj Bose, Srdan VerstovsekClinical Lymphoma, Myeloma & Leukemia|February 16, 2023
SOHO State of the Art Updates and Next Questions: Novel Therapeutic Strategies in Development for MyelofibrosisHelen T Chifotides, Lucia Masarova, Srdan VerstovsekExpert Review of Hematology|August 12, 2017
Immunotherapy based approaches in myelofibrosisLucia Masarova, Srdan Verstovsek, Hagop Kantarjian, et al.Clinical Lymphoma, Myeloma & Leukemia|November 29, 2021
SOHO State of the Art Updates and Next Questions: Novel Therapies in Development for MyelofibrosisHelen T Chifotides, Prithviraj Bose, Lucia Masarova, et al.Pageof 63